formoterol fumarate
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pulmonary Disease, Chronic Obstructive
Conditions
Pulmonary Disease, Chronic Obstructive
Trial Timeline
Sep 1, 2005 → Nov 21, 2006
NCT ID
NCT00139932About formoterol fumarate
formoterol fumarate is a approved stage product being developed by Merck for Pulmonary Disease, Chronic Obstructive. The current trial status is completed. This product is registered under clinical trial identifier NCT00139932. Target conditions include Pulmonary Disease, Chronic Obstructive.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00139932 | Approved | Completed |
Competing Products
20 competing products in Pulmonary Disease, Chronic Obstructive